Enara Health is a technology company.
Enara Health has raised $6.0M across 1 funding round.
Enara Health has raised $6.0M in total across 1 funding round.
Enara Health is a San Mateo, California-based technology company building a data-driven platform and network to scale obesity treatment for patients and independent clinics.[1][2][5] It offers a clinically proven, insurance-covered weight management program that delivers sustainable results through personalized plans combining metabolic insights, medications like GLP-1s, genetic testing, diet design, exercise, and emotional support—achieving up to 20% weight loss at 18 months with medications and consistent outcomes through 36 months.[3][4] Serving patients directly and partnering with medical groups and small-to-medium clinics across six states, Enara solves the obesity crisis—affecting over 110 million U.S. adults—by enabling accessible, culturally tailored care, automating prior authorizations, and optimizing operations via AI for billing and service coverage, particularly in underserved minority communities.[1][3] Growth includes partner clinics in multiple states and a focus on network expansion for broader reach.[3][4]
Enara Health was founded in 2014 (with operations noted from March 2015) in San Mateo, California, as a provider of weight management programs in the healthcare sector.[2][5] Specific founders are not detailed in available sources, but the company emerged amid rising demand for scalable obesity solutions, integrating mobile technology with medical care like physician consultations, lifestyle evaluations, diet, and medication management.[1][2] Early traction built on addressing the obesity epidemic's role in chronic diseases, with pivotal growth through digital tools for clinics and recognition as a Great Place to Work by 2023, reflecting strong internal culture amid expansion.[1][7] By 2024, initiatives like AI-driven operations and prior authorization automation marked key milestones in empowering independent practices.[1][4]
Enara stands out in digital health and telehealth through these key features:
Enara rides the digital health and telehealth boom, fueled by GLP-1 medications like Ozempic and rising obesity rates driving demand for scalable, non-surgical treatments.[2][3] Timing aligns with post-pandemic telehealth adoption and insurer coverage expansions, countering prior authorization hurdles that cause 1 in 4 physicians to report serious patient risks.[4] Market forces favoring Enara include the $100B+ U.S. obesity market, AI/health data infrastructure growth, and shifts from "sick care" to preventive models, as noted by its chief medical officer.[1][2] It influences the ecosystem by networking independent clinics, boosting access in underserved areas, and setting standards for data-driven, equitable weight care amid 11,000+ digital health players.[1][2][3]
Enara Health is poised to expand its clinic network nationwide, leveraging AI enhancements and GLP-1 momentum for deeper insurance penetration and non-med outcomes.[1][3][4] Trends like AI-optimized care, regulatory support for telehealth, and obesity's chronic disease links will shape growth, potentially positioning it as a leader in value-based weight management. Its influence may evolve by standardizing clinic ops and reducing disparities, amplifying impact as partners scale—reinforcing its role in transforming U.S. healthcare from reactive to sustainable.
Enara Health has raised $6.0M in total across 1 funding round.
Enara Health's investors include Andreessen Horowitz, Blu Venture Investors, ClimacticVC, Endeavor8, Four Rivers Group, Global Founders Capital, Neotribe Ventures, Preface Ventures, Scale Asia Ventures, SNR, SRB Ventures, True Ventures.
Enara Health has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2022 | $6.0M Seed | Andreessen Horowitz, Blu Venture Investors, ClimacticVC, Endeavor8, Four Rivers Group, Global Founders Capital, Neotribe Ventures, Preface Ventures, Scale Asia Ventures, SNR, SRB Ventures, True Ventures, Oleg Rogynskyy, Siqi Chen, Tom Williams |